FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Raphael Viscidi

Research Profile

Chemicals & Drugs

Disorders

Living Beings

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Jie Li; Erica Silberstein; Deborah R Taylor; Laura Ulitzky; Raphael P Viscidi
Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates.
Patti Gravitt; Morgan A Marks; Anne F Rositch; Michelle I Silver; Anne E Burke; Kathryn Chang; Raphael P Viscidi
A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.
Jianchun Xiao; Robert H Yolken; Geetha Kannan; Ye Li; Jun Nomura; Emily G Severance; Raphael P Viscidi; Laurence DELHAEs
The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Raphael Viscidi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jie Li; Erica Silberstein; Deborah R Taylor; Laura Ulitzky; Raphael P Viscidi
Immunogenicity and Protection Efficacy of Monomeric and Trimeric Recombinant SARS Coronavirus Spike Protein Subunit Vaccine Candidates.
Viral immunology 2013;26(2):126-32.
2013: Patti Gravitt; Morgan A Marks; Anne F Rositch; Michelle I Silver; Anne E Burke; Kathryn Chang; Raphael P Viscidi
A cohort effect of the sexual revolution may be masking an increase in human papillomavirus detection at menopause in the United States.
The Journal of infectious diseases 2013;207(2):272-80.
2013: Jianchun Xiao; Robert H Yolken; Geetha Kannan; Ye Li; Jun Nomura; Emily G Severance; Raphael P Viscidi; Laurence DELHAEs
The Toxoplasma MAG1 peptides induce sex-based humoral immune response in mice and distinguish active from chronic human infection.
Microbes and infection / Institut Pasteur 2013;15(1):74-83.
2013: Anne F Rositch; Wen Shen; Michelle I Silver; Raphael P Viscidi; Anne Burke; Kathryn Chang; Cindy M P Duke; Patti Gravitt
The correlation between human papillomavirus positivity and abnormal cervical cytology result differs by age among perimenopausal women.
Journal of lower genital tract disease 2013;17(1):38-47.
2012: Anne F Rositch; Michelle I Silver; Raphael P Viscidi; Anne E Burke; Kathryn Chang; Patti Gravitt
Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.
Cancer research 2012;72(23):6183-90.
2012: Claudia Robles; Raphael P Viscidi; Eva Gonzalez-Barca; Andre Poloczek; Yolanda Benavente; Ramon Bosch; Delphine Casabonne; Silvia de Sanjosé
Antibody response to Merkel cell polyomavirus associated with incident lymphoma in the Epilymph case-control study in Spain.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1592-8.
2012: Beibei Lu; Alan G Nyitray; Mary Papenfuss; Manuel Quiterio; Jorge Salmerón; Danelle C Smith; Luisa L Villa; Raphael P Viscidi; Yougui Wu; Martha Abrahamsen; Maria Luiza Baggio; Roberto J Carvalho da Silva; Eduardo Lazcano-Ponce; Anna R Giuliano
Seroprevalence of human papillomavirus (HPV) type 6 and 16 vary by anatomic site of HPV infection in men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(9):1542-6.
2012: Qi Zeng; Bianca P Gomez; Liangmei He; Barbara Ma; Shiwen Peng; Raphael P Viscidi; Tzyy-choou Wu; Chien-Fu Hung
Development of a DNA vaccine targeting Merkel cell polyomavirus.
Vaccine 2012;30(7):1322-9.
2012: Sarah M Tiggelaar; Raphael P Viscidi; Jia Ji; Margaret J Lin; Jennifer S Smith
Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global review.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2012;50(2):110-31.
2012: Beibei Lu; Alan G Nyitray; Mary R Papenfuss; Manuel Quiterio; Jorge Salmeron; Danelle C Smith; Heather G Stockwell; Luisa L Villa; Raphael P Viscidi; Yougui Wu; Martha E Abrahamsen; Maria Luiza Baggio; Roberto J Carvalho da Silva; Eduardo Lazcano-Ponce; Ji-Hyun Lee; Anna R Giuliano
Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men.
Cancer research 2012;72(3):676-85.
2012: Bianca P Gomez; Liangmei He; Shiwen Peng; Raphael P Viscidi; Connie Wang; Tzyy-choou Wu; Chien-Fu Hung
Strategy for eliciting antigen-specific CD8+ T cell-mediated immune response against a cryptic CTL epitope of merkel cell polyomavirus large T antigen.
Cell & bioscience 2012;2(1):36.
2012: Diana V Pastrana; Parmjeet S Randhawa; Gregory A Storch; Raphael P Viscidi; Daniel C Brennan; Nicolas Cuburu; Christopher B Buck
Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients.
PLoS pathogens 2012;8(4):e1002650.
2011: Morgan A Marks; Michelle Silver; Raphael P Viscidi; Anne Burke; Kathryn Chang; Roslyn Howard; Patti Gravitt
Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women.
Cytokine 2011;56(3):798-803.
2011: Raphael P Viscidi; Dana E Rollison; Barbara Silver; Vernon K Sondak; Abidemi Ajidahun; William Fulp; Anna R Giuliano; Jane L Messina; Daniela Rivanera
Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.
Clinical and vaccine immunology : CVI 2011;18(10):1737-43.
2011: Raphael P Viscidi; David B Clifford; Hans H Hirsch; Lisa P Jacobson; Nina Khanna; Xiuhung Li; Joseph B Margolick; Avindra Nath; Keerti V Shah; Chen S Tan; Igor J Koralnik
JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1-infected individuals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(7):711-5.
2011: Nicolas Wentzensen; Ana Cecilia Rodriguez; Raphael P Viscidi; Rolando Herrero; Allan Hildesheim; Arpita Ghosh; Jorge Morales; Sholom Wacholder; Diego Guillen; Mario Alfaro; Mahboobeh Safaeian; Robert D Burk; Mark Schiffman
A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the Guanacaste Natural History Study.
The Journal of infectious diseases 2011;204(1):94-102.
2011: Beibei Lu; Raphael P Viscidi; Ji-Hyun Lee; Yougui Wu; Luisa L Villa; Eduardo Lazcano-Ponce; Maria Luiza Baggio; Manuel Quiterio; jorge salmeron; Danelle C Smith; Martha Abrahamsen; Mary Papenfuss; Heather G Stockwell; Roberto J Carvalho da Silva; Anna R Giuliano
Human papillomavirus (HPV) 6, 11, 16, and 18 seroprevalence is associated with sexual practice and age: results from the multinational HPV Infection in Men Study (HIM Study).
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011;20(5):990-1002.
2011: Renzo Boldorini; Sara Allegrini; Umberto Miglio; Alessia Paganotti; Norma Cocca; Mauro Zaffaroni; Francesca Riboni; Guido Monga; Raphael P Viscidi
Serological evidence of vertical transmission of JC and BK polyomaviruses in humans.
The Journal of general virology 2011;92(Pt 5):1044-50.
2011: Sarven Sabunciyan; Nataniel Mandelberg; Charles S Rabkin; Robert H Yolken; Raphael P Viscidi
No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls.
Molecular and cellular probes 2011;25(2-3):134-6.
2011: Emily G Severance; Faith B Dickerson; Raphael P Viscidi; Ioannis Bossis; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken
Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms.
Schizophrenia bulletin 2011;37(1):101-7.
2010: Mahboobeh Safaeian; Koen Quint; Mark Schiffman; Ana Cecilia Rodriguez; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Raphael P Viscidi; Wim Quint; Robert D Burk
Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort.
Journal of the National Cancer Institute 2010;102(23):1794-804.
2010: Sharmila Pejawar-Gaddy; Yogendra Rajawat; Zoe Hilioti; Jia Xue; Daniel F Gaddy; Olivera J Finn; Raphael P Viscidi; Ioannis Bossis
Generation of a tumor vaccine candidate based on conjugation of a MUC1 peptide to polyionic papillomavirus virus-like particles.
Cancer immunology, immunotherapy : CII 2010;59(11):1685-96.
2010: Jill Koshiol; Wen-Qiang Wei; Aimée R Kreimer; Wen Chen; Patti Gravitt; Jian-Song Ren; Christian C Abnet; Jian-Bing Wang; Farin Kamangar; Dong-Mei Lin; Magnus von Knebel Doeberitz; Yu Zhang; Raphael P Viscidi; Guo-Qing Wang; Maura L Gillison; Mark J Roth; Zhi-Wei Dong; Esther Kim; Philip R Taylor; You-Lin Qiao; Sanford M Dawsey
No role for human papillomavirus in esophageal squamous cell carcinoma in China.
International journal of cancer. Journal international du cancer 2010;127(1):93-100.
2010: Regan N Theiler; Sherry L Farr; John M Karon; Pangaja Paramsothy; Raphael P Viscidi; Ann Duerr; Susan Cu-Uvin; Jack D Sobel; Keerti V Shah; Robert S Klein; Denise J Jamieson
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding.
Obstetrics and gynecology 2010;115(6):1150-8.
2010: Chen S Tan; Yiping Chen; Raphael P Viscidi; R Philip Kinkel; Marion C Stein; Igor J Koralnik
Discrepant findings in immune responses to JC virus in patients receiving natalizumab.
Lancet neurology 2010;9(6):565-6; author reply 566-7.
2010: Raphael P Viscidi; Keerti V Shah
Adult male circumcision: will it reduce disease caused by human papillomavirus?
The Journal of infectious diseases 2010;201(10):1447-9.
2010: Vanesa Bijol; Adela Cimic; Raphael P Viscidi; Leonard C Hymes
Pretransplant IgG antibodies to polyoma BK virus in pediatric renal transplants.
Pediatric transplantation 2010;14(2):224-7.
2010: Siobhan Sutcliffe; Raphael P Viscidi; Cathee Till; Phyllis J Goodman; Ashraful M Hoque; Ann W Hsing; Ian M Thompson; Jonathan M Zenilman; Angelo M DeMarzo; Elizabeth A Platz
Human papillomavirus types 16, 18, and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(2):614-8.
2010: Loubna Tazi; Marcos Pérez-Losada; Weiming Gu; Yang Yang; Lin Xue; Keith A Crandall; Raphael P Viscidi
Population dynamics of Neisseria gonorrhoeae in Shanghai, China: a comparative study.
BMC infectious diseases 2010;10():13.
2009: Siobhan Sutcliffe; Ichiro Kawachi; John F Alderete; Charlotte A Gaydos; Lisa P Jacobson; Frank J Jenkins; Raphael P Viscidi; Jonathan M Zenilman; Elizabeth A Platz
Correlates of sexually transmitted infection histories in a cohort of American male health professionals.
Cancer causes & control : CCC 2009;20(9):1623-34.
2009: Jianchun Xiao; Stephen L Buka; Tyrone D Cannon; Yasuhiro Suzuki; Raphael P Viscidi; E Fuller Torrey; Robert H Yolken
Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring.
Microbes and infection / Institut Pasteur 2009;11(13):1011-8.
2009: Yiping Chen; Evelyn Bord; Troy Tompkins; Janice Miller; Chen S Tan; R Philip Kinkel; Marion C Stein; Raphael P Viscidi; Long H Ngo; Igor J Koralnik
Asymptomatic reactivation of JC virus in patients treated with natalizumab.
The New England journal of medicine 2009;361(11):1067-74.
2009: Keri Nicole Althoff; Proma Paul; Anne E Burke; Raphael P Viscidi; Meera Sangaramoorthy; Patti Gravitt
Correlates of cervicovaginal human papillomavirus detection in perimenopausal women.
Journal of women's health (2002) 2009;18(9):1341-6.
2009: Bala Ramaswami; Iulia Popescu; Camila Macedo; Diana Metes; Marta Bueno; Adriana Zeevi; Ron Shapiro; Raphael P Viscidi; Parmjeet S Randhawa
HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.
Human immunology 2009;70(9):722-8.
2009: Mary K Grabowski; Raphael P Viscidi; Joseph B Margolick; Lisa P Jacobson; Keerti V Shah
Investigation of pre-diagnostic virological markers for progressive multifocal leukoencephalopathy in human immunodeficiency virus-infected patients.
Journal of medical virology 2009;81(7):1140-50.
2009: Christian Wüthrich; Xin Dang; Susan Westmoreland; John McKay; Atul Maheshwari; Matthew Peter Anderson; Allan H Ropper; Raphael P Viscidi; Igor J Koralnik
Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons.
Annals of neurology 2009;65(6):742-8.
2009: Mark Einstein; John T Schiller; Raphael P Viscidi; Howard D Strickler; Pierre Coursaget; Tina Tan; Neal A Halsey; David Jenkins
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
The Lancet infectious diseases 2009;9(6):347-56.
2009: Dana E Rollison; Kathy J Helzlsouer; Ji-Hyun Lee; William Fulp; SANDRA CLIPP; Judy A Hoffman-Bolton; Anna R Giuliano; Elizabeth A Platz; Raphael P Viscidi
Prospective study of JC virus seroreactivity and the development of colorectal cancers and adenomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(5):1515-23.
2009: Nina Khanna; Marcel Wolbers; Nicolas J Mueller; Christian Garzoni; Renaud A Du Pasquier; Christoph A Fux; Pietro Vernazza; Enos Bernasconi; Raphael P Viscidi; Manuel Battegay; Hans Hirsch
JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Journal of virology 2009;83(9):4404-11.
2009: Parmjeet Randhawa; Raphael P Viscidi; Joseph J Carter; Denise A Galloway; Tim D Culp; Cathy Huang; Bala Ramaswami; Neil D Christensen
Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies.
The Journal of general virology 2009;90(Pt 3):634-9.
2009: Cornelia L Trimble; Shiwen Peng; FERDYNAND KOS; Patti Gravitt; Raphael P Viscidi; Elizabeth Sugar; Drew M Pardoll; Tzyy-choou Wu
A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):361-7.
2008: Emily G Severance; Ioannis Bossis; Faith B Dickerson; Cassie R Stallings; Andrea E Origoni; Anne Sullens; Robert H Yolken; Raphael P Viscidi
Development of a nucleocapsid-based human coronavirus immunoassay and estimates of individuals exposed to coronavirus in a U.S. metropolitan population.
Clinical and vaccine immunology : CVI 2008;15(12):1805-10.
2008: Parmjeet Randhawa; D Bohl; D Brennan; Kristine Ruppert; B Ramaswami; G Storch; J March; Ron Shapiro; Raphael P Viscidi
longitudinal analysis of levels of immunoglobulins against BK virus capsid proteins in kidney transplant recipients.
Clinical and vaccine immunology : CVI 2008;15(10):1564-71.
2008: Wen-Yi Huang; Richard Hayes; Ruth Pfeiffer; Raphael P Viscidi; Francis K Lee; Yun F Wang; Douglas Reding; Denise Whitby; John R Papp; Charles S Rabkin
Sexually transmissible infections and prostate cancer risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(9):2374-81.
2008: Faith B Dickerson; Elizabeth Rubalcaba; Raphael P Viscidi; Shuojia Yang; Cassie Stallings; Anne Sullens; Andrea Origoni; Flora Leister; Robert H Yolken
Polymorphisms in human endogenous retrovirus K-18 and risk of type 2 diabetes in individuals with schizophrenia.
Schizophrenia research 2008;104(1-3):121-6.
2008: Staffan Görander; Teresa Lagergård; Malgorzata Romanik; Raphael P Viscidi; Gayane Martirosian; Jan-Ake Liljeqvist
Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
Clinical and vaccine immunology : CVI 2008;15(4):675-80.
2008: Maura L Gillison; Gypsyamber D'Souza; William H Westra; Elizabeth Sugar; Weihong Xiao; Shahnaz Begum; Raphael P Viscidi
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
Journal of the National Cancer Institute 2008;100(6):407-20.
2008: Antonio Carvajal-Rodríguez; David Posada; Marcos Pérez-Losada; Emily Keller; Elaine J Abrams; Raphael P Viscidi; Keith A Crandall
Disease progression and evolution of the HIV-1 env gene in 24 infected infants.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2008;8(2):110-20.
2008: Javier Pintos; Martin J Black; Nader Sadeghi; Parviz Ghadirian; Anthony G Zeitouni; Raphael P Viscidi; Rolando Herrero; François Coutlée; Eduardo L Franco
Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada.
Oral oncology 2008;44(3):242-50.
2008: Raphael P Viscidi; Keerti V Shah
Cancer. A skin cancer virus?
Science (New York, N.Y.) 2008;319(5866):1049-50.
2008: I J Wang; Raphael P Viscidi; K C Hwang; T Y Lin; C J Chen; L M Huang; H H Chen; C J Chen
Seroprevalence and risk factors for human papillomavirus in Taiwan.
Journal of tropical pediatrics 2008;54(1):14-8.
2007: Sabrina S Plitt; Susan G Sherman; Raphael P Viscidi; Steffanie A Strathdee; Crystal M Fuller; Taha E Taha
Human papillomavirus seroprevalence among young male and female drug users.
Sexually transmitted diseases 2007;34(9):676-80.
2007: Annika Lundstig; Pär Stattin; Kenneth Persson; Kestutis Sasnauskas; Raphael P Viscidi; Randi Gislefoss; Joakim Dillner
No excess risk for colorectal cancer among subjects seropositive for the JC polyomavirus.
International journal of cancer. Journal international du cancer 2007;121(5):1098-102.
2007: Siobhan Sutcliffe; Edward Giovannucci; Charlotte A Gaydos; Raphael P Viscidi; Frank J Jenkins; Jonathan M Zenilman; Lisa P Jacobson; Angelo M DeMarzo; Walter C Willett; Elizabeth A Platz
Plasma antibodies against Chlamydia trachomatis, human papillomavirus, and human herpesvirus type 8 in relation to prostate cancer: a prospective study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(8):1573-80.
2007: Ana Cecilia Rodriguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Concepción Bratti; Mark E Sherman; Diane Solomon; Diego Guillen; Mario Alfaro; Raphael P Viscidi; Jorge Morales; Martha Hutchinson; Sholom Wacholder; Mark Schiffman
The natural history of human papillomavirus infection and cervical intraepithelial neoplasia among young women in the Guanacaste cohort shortly after initiation of sexual life.
Sexually transmitted diseases 2007;34(7):494-502.
2007: Gypsyamber D'Souza; Aimée R Kreimer; Raphael P Viscidi; Michael Pawlita; Carole Fakhry; Wayne M Koch; William H Westra; Maura L Gillison
Case-control study of human papillomavirus and oropharyngeal cancer.
The New England journal of medicine 2007;356(19):1944-56.
2007: Marcos Pérez-Losada; Keith A Crandall; Jonathan M Zenilman; Raphael P Viscidi
Temporal trends in gonococcal population genetics in a high prevalence urban community.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2007;7(2):271-8.
2007: Chih-Jung Chen; Raphael P Viscidi; Chih-Hsien Chuang; Yhu-Chering Huang; Cheng-Hsun Chiu; Tzou-Yien Lin
Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;38(2):126-30.
2007: Judica Mbwana; Raphael P Viscidi; Eligius Lyamuya; Fred Mhalu; G Chalamilla; Jan-Ake Liljeqvist; Teresa Lagergård
Prevalence of serum antibodies to human papilloma virus in patients with genital ulcer disease in an urban population of Tanzania.
Sexually transmitted infections 2007;83(1):64-5.
2007: Raphael P Viscidi; Keerti V Shah
Should human papillomavirus vaccination be mandatory?
The virtual mentor : VM 2007;9(12):823-6.
2007: Marcos Pérez-Losada; Keith A Crandall; Margaret C Bash; Michael Dan; Jonathan M Zenilman; Raphael P Viscidi
Distinguishing importation from diversification of quinolone-resistant Neisseria gonorrhoeae by molecular evolutionary analysis.
BMC evolutionary biology 2007;7():84.
2006: Ratish Gambhira; Patti Gravitt; Ioannis Bossis; Peter L Stern; Raphael P Viscidi; Richard B S Roden
Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Cancer research 2006;66(23):11120-4.
2006: Charles T T Edwards; Edward C Holmes; Oliver G Pybus; Daniel J Wilson; Raphael P Viscidi; E J Abrams; Rodney E Phillips; Alexei J Drummond
Evolution of the human immunodeficiency virus envelope gene is dominated by purifying selection.
Genetics 2006;174(3):1441-53.
2006: Ligia A Pinto; Raphael P Viscidi; Clayton D Harro; Troy J Kemp; Alfonso J García-Piñeres; Matthew Trivett; Franklin Demuth; Douglas Lowy; John T Schiller; Jay A Berzofsky; Allan Hildesheim
Cellular immune responses to HPV-18, -31, and -53 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles.
Virology 2006;353(2):451-62.
2006: Parmjeet S Randhawa; Gaurav Gupta; Abhay Vats; Ron Shapiro; Raphael P Viscidi
Immunoglobulin G, A, and M responses to BK virus in renal transplantation.
Clinical and vaccine immunology : CVI 2006;13(9):1057-63.
2006: Marcos Pérez-Losada; Ryan Christensen; David A McClellan; Byron J Adams; Raphael P Viscidi; James C Demma; Keith A Crandall
Comparing phylogenetic codivergence between polyomaviruses and their hosts.
Journal of virology 2006;80(12):5663-9.
2006: Lisa Jones-Engel; Gregory A Engel; John Heidrich; Mukesh Chalise; Narayan Poudel; Raphael P Viscidi; Peter A Barry; Jonathan S Allan; Richard Grant; Randall C Kyes
Temple monkeys and health implications of commensalism, Kathmandu, Nepal.
Emerging infectious diseases 2006;12(6):900-6.
2006: Michael J Silverberg; Michael F Schneider; Barbara Silver; Kathryn Anastos; Robert D Burk; Howard Minkoff; Joel Palefsky; Alexandra M Levine; Raphael P Viscidi
Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
Clinical and vaccine immunology : CVI 2006;13(4):511-9.
2006: Dana E Rollison; Eric A Engels; Neal A Halsey; Keerti V Shah; Raphael P Viscidi; Kathy J Helzlsouer
Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(3):543-50.
2006: Marcos Pérez-Losada; Emily B Browne; Aaron Madsen; Thierry Wirth; Raphael P Viscidi; Keith A Crandall
Population genetics of microbial pathogens estimated from multilocus sequence typing (MLST) data.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2006;6(2):97-112.
2006: Raphael P Viscidi; Barbara Clayman
Serological cross reactivity between polyomavirus capsids.
Advances in experimental medicine and biology 2006;577():73-84.
2006: Keith A Crandall; Marcos Pérez-Losada; Ryan Christensen; David A McClellan; Raphael P Viscidi
Phylogenomics and molecular evolution of polyomaviruses.
Advances in experimental medicine and biology 2006;577():46-59.
2006: Charles T T Edwards; Edward C Holmes; Daniel J Wilson; Raphael P Viscidi; Elaine J Abrams; Rodney E Phillips; Alexei J Drummond
Population genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.
BMC evolutionary biology 2006;6():28.
2005: Eric A Engels; Dana E Rollison; Patricia Hartge; Dalsu Baris; James Cerhan; Richard K Severson; Wendy Cozen; Scott Davis; Robert J Biggar; James J Goedert; Raphael P Viscidi
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.
International journal of cancer. Journal international du cancer 2005;117(6):1013-9.
2005: Sundaram Hariharan; Eric P Cohen; Brahm Vasudev; Rimas Orentas; Raphael P Viscidi; Justin Kakela; Brian DuChateau
BK virus-specific antibodies and BKV DNA in renal transplant recipients with BKV nephritis.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(11):2719-24.
2005: Alice de M Zelmanowicz; Mark Schiffman; Rolando Herrero; Alisa M Goldstein; Mark E Sherman; Robert D Burk; Patti Gravitt; Raphael P Viscidi; Peter Schwartz; Willard A Barnes; Rodrigue Mortel; Steven G Silverberg; Julie Buckland; Allan Hildesheim
Family history as a co-factor for adenocarcinoma and squamous cell carcinoma of the uterine cervix: results from two studies conducted in Costa Rica and the United States.
International journal of cancer. Journal international du cancer 2005;116(4):599-605.
2005: Marcos Pérez-Losada; Raphael P Viscidi; James C Demma; Jonathan M Zenilman; Keith A Crandall
Population genetics of Neisseria gonorrhoeae in a high-prevalence community using a hypervariable outer membrane porB and 13 slowly evolving housekeeping genes.
Molecular biology and evolution 2005;22(9):1887-902.
2005: Rongcun Yang; Francisco Martinez Murillo; Michael J Delannoy; Richard Blosser; Wil Yutzy; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(12):7912-9.
2005: Aimée R Kreimer; Gary M Clifford; Peter J F Snijders; Xavier Castellsagué; Chris J L M Meijer; Michael Pawlita; Raphael P Viscidi; Rolando Herrero; Silvia Franceschi
HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas.
International journal of cancer. Journal international du cancer 2005;115(2):329-32.
2005: Dana E Rollison; Kathy J Helzlsouer; Neal A Halsey; Keerti V Shah; Raphael P Viscidi
Markers of past infection with simian virus 40 (SV40) and risk of incident non-Hodgkin lymphoma in a Maryland cohort.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1448-52.
2005: Rongcun Yang; Cosette M Wheeler; Xiaojiang S Chen; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Diana V Pastrana; Raphael P Viscidi; Richard B S Roden
Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Journal of virology 2005;79(11):6741-50.
2005: Eric A Engels; Jinbo Chen; Patricia Hartge; James Cerhan; Scott Davis; Richard K Severson; Wendy Cozen; Raphael P Viscidi
Antibody responses to simian virus 40 T antigen: a case-control study of non-Hodgkin lymphoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(2):521-4.
2005: Raphael P Viscidi; Brad Snyder; Susan Cu-Uvin; Joseph W Hogan; Barbara Clayman; Robert S Klein; Jack D Sobel; Keerti V Shah
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):283-8.
2004: Eric A Engels; William Switzer; Walid Heneine; Raphael P Viscidi
Serologic evidence for exposure to simian virus 40 in North American zoo workers.
The Journal of infectious diseases 2004;190(12):2065-9.
2004: Sophia S Wang; Mark Schiffman; Rolando Herrero; Joseph D Carreon; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica.
British journal of cancer 2004;91(7):1269-74.
2004: Rongcun Yang; Francisco Martinez Murillo; Hengmi Cui; Richard Blosser; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88.
Journal of virology 2004;78(20):11152-60.
2004: Eric A Engels; Raphael P Viscidi; Denise A Galloway; Joseph J Carter; James Cerhan; Scott Davis; Wendy Cozen; Richard K Severson; Silvia de Sanjose; Joanne S Colt; Patricia Hartge
Case-control study of simian virus 40 and non-Hodgkin lymphoma in the United States.
Journal of the National Cancer Institute 2004;96(18):1368-74.
2004: Rongcun Yang; Francisco Martinez Murillo; Ken-Yu Lin; Wil Yutzy; Satoshi Uematsu; Kiyoshi Takeda; Shizuo Akira; Raphael P Viscidi; Richard B S Roden
Human papillomavirus type-16 virus-like particles activate complementary defense responses in key dendritic cell subpopulations.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(4):2624-31.
2004: Eric A Engels; J Chen; Raphael P Viscidi; Keerti V Shah; Richard W Daniel; N Chatterjee; M A Klebanoff
Poliovirus vaccination during pregnancy, maternal seroconversion to simian virus 40, and risk of childhood cancer.
American journal of epidemiology 2004;160(4):306-16.
2004: Philip E Castle; Mark Schiffman; M Concepcion Bratti; Allan Hildesheim; Rolando Herrero; Martha L Hutchinson; Ana Cecilia Rodriguez; Sholom Wacholder; Mark E Sherman; Hortense Kendall; Raphael P Viscidi; Jose Jeronimo; John E Schussler; Robert D Burk
A population-based study of vaginal human papillomavirus infection in hysterectomized women.
The Journal of infectious diseases 2004;190(3):458-67.
2004: Keerti V Shah; Denise A Galloway; Wendy Knowles; Raphael P Viscidi
Simian virus 40 (SV40) and human cancer: a review of the serological data.
Reviews in medical virology 2004;14(4):231-9.
2004: Tae Woo Kim; Jin Hyup Lee; Chien-Fu Hung; Shiwen Peng; Richard B S Roden; Mei-Cheng Wang; Raphael P Viscidi; Ya-Chea Tsai; Liangmei He; Pei-Jer Chen; David A K Boyd; Tzyy-choou Wu
Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.
Journal of virology 2004;78(9):4638-45.
2004: Aimée R Kreimer; Anthony J Alberg; Raphael P Viscidi; Maura L Gillison
Gender differences in sexual biomarkers and behaviors associated with human papillomavirus-16, -18, and -33 seroprevalence.
Sexually transmitted diseases 2004;31(4):247-56.
2004: Aimée R Kreimer; Anthony J Alberg; Richard Daniel; Patti Gravitt; Raphael P Viscidi; Elizabeth Garrett-Mayer; Keerti V Shah; Maura L Gillison
Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus.
The Journal of infectious diseases 2004;189(4):686-98.
2004: Raphael P Viscidi; Mark Schiffman; Allan Hildesheim; Rolando Herrero; Philip E Castle; M Concepcion Bratti; Ana Cecilia Rodriguez; Mark E Sherman; Sophia Wang; Barbara Clayman; Robert D Burk
Seroreactivity to human papillomavirus (HPV) types 16, 18, or 31 and risk of subsequent HPV infection: results from a population-based study in Costa Rica.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(2):324-7.
2003: Raphael P Viscidi; Linda Ahdieh-Grant; Michael F Schneider; Barbara Clayman; L Stewart Massad; Kathryn Anastos; Robert D Burk; Howard Minkoff; Joel Palefsky; Alexandra M Levine; Howard D Strickler
Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
The Journal of infectious diseases 2003;188(12):1834-44.
2003: Rolando Herrero; Xavier Castellsagué; Michael Pawlita; Jolanta Lissowska; Frank Kee; Prabda Balaram; THANGARAJAN RAJKUMAR; Hema Sridhar; Barbara Rose; Javier Pintos; Leticia Fernández; Ali Idris; María José Sánchez; Adoración Nieto; Renato Talamini; Alessandra Tavani; F Xavier Bosch; Ulrich Reidel; Peter J F Snijders; Chris J L M Meijer; Raphael P Viscidi; Nubia Muñoz; Silvia Franceschi
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study.
Journal of the National Cancer Institute 2003;95(23):1772-83.
2003: Ana Cecilia Rodríguez; Philip E Castle; Jennifer Smith; Concepción Bratti; Allan Hildesheim; Mark Schiffman; Raphael P Viscidi; Robert D Burk; R L Ashley; Xavier Castellsagué; Rolando Herrero
A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica.
Sexually transmitted infections 2003;79(6):460-5.
2003: Sophia S Wang; Mark Schiffman; Tammy Shields; Rolando Herrero; Allan Hildesheim; M Concepcion Bratti; Mark E Sherman; Ana Cecilia Rodriguez; Philip E Castle; Jorge Morales; Mario Alfaro; T Wright; S Chen; Barbara Clayman; Robert D Burk; Raphael P Viscidi
Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10000 women in Costa Rica.
British journal of cancer 2003;89(7):1248-54.
2003: Silvia de Sanjose; Keerti V Shah; Eva Domingo-Domenech; Eric A Engels; Alberto Fernandez de Sevilla; Tomás Alvaro; Mercedes Garcia-Villanueva; Vicens Romagosa; Eva Gonzalez-Barca; Raphael P Viscidi
Lack of serological evidence for an association between simian virus 40 and lymphoma.
International journal of cancer. Journal international du cancer 2003;104(4):522-4.
2003: Rongcun Yang; Wil Yutzy; Raphael P Viscidi; Richard B S Roden
Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.
The Journal of biological chemistry 2003;278(14):12546-53.
2003: Raphael P Viscidi; Dana E Rollison; Emma Viscidi; Barbara Clayman; Elizabeth Rubalcaba; Richard Daniel; Eugene O Major; Keerti V Shah
Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.
Clinical and diagnostic laboratory immunology 2003;10(2):278-85.
2003: Raphael P Viscidi; Linda Ahdieh-Grant; Barbara Clayman; Kelly Fox; L Stewart Massad; Susan Cu-Uvin; Keerti V Shah; Kathryn Anastos; Kathleen E Squires; Ann Duerr; Denise J Jamieson; Robert D Burk; Robert S Klein; Howard Minkoff; Joel Palefsky; Howard D Strickler; Paula Schuman; Eva Piessens; Paolo Miotti
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
The Journal of infectious diseases 2003;187(2):194-205.
2003: Raphael P Viscidi; James C Demma
Genetic diversity of Neisseria gonorrhoeae housekeeping genes.
Journal of clinical microbiology 2003;41(1):197-204.
2002: Mayumi Nakagawa; Raphael P Viscidi; Ian Deshmukh; Maria Da Costa; Joel Palefsky; Sepideh Farhat; Anna-Barbara Moscicki
Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women.
Clinical and diagnostic laboratory immunology 2002;9(4):877-82.
2002: jianchao zong; Dolores M Ciufo; Raphael P Viscidi; Lee Alagiozoglou; Stephen Tyring; Peter L Rady; Jan Orenstein; William Boto; Henry Kalumbuja; n romano; Mads Melbye; Gyeong Hoon Kang; Chris Boshoff; Gary S Hayward
Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2002;23(3):119-48.
2000: Raphael P Viscidi; James C Demma; J Gu; Jonathan M Zenilman
Comparison of sequencing of the por gene and typing of the opa gene for discrimination of Neisseria gonorrhoeae strains from sexual contacts.
Journal of clinical microbiology 2000;38(12):4430-8.
2000: Anthony J Alberg; J Selhub; Keerti V Shah; Raphael P Viscidi; George W Comstock; Kathy J Helzlsouer
The risk of cervical cancer in relation to serum concentrations of folate, vitamin B12, and homocysteine.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2000;9(7):761-4.
2000: E L Hinton; L D Bobo; Tzyy-choou Wu; Robert J Kurman; Raphael P Viscidi
Detection of Chlamydia trachomatis DNA in archival paraffinized specimens from chronic salpingitis cases using the polymerase chain reaction.
Fertility and sterility 2000;74(1):152-7.
2000: David Posada; Keith A Crandall; M Nguyen; James C Demma; Raphael P Viscidi
Population genetics of the porB gene of Neisseria gonorrhoeae: different dynamics in different homology groups.
Molecular biology and evolution 2000;17(3):423-36.
1999: XIAOFANG YU; Jie Chen; Y Shao; CHRISTOPHER BEYRER; Bindong Liu; Zhaojie Wang; Wei Liu; J Yang; S Liang; Raphael P Viscidi; J Gu; G Gurri-Glass; Shenghan Lai
Emerging HIV infections with distinct subtypes of HIV-1 infection among injection drug users from geographically separate locations in Guangxi Province, China.
Journal of acquired immune deficiency syndromes (1999) 1999;22(2):180-8.
1999: Y Sun; José Eluf-Neto; F X Bosch; N Muñoz; Jan M M Walboomers; C J Meijer; Keerti V Shah; Barbara Clayman; Raphael P Viscidi
Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1999;8(10):935-40.
1999: Howard D Strickler; Raphael P Viscidi; Carlos Escoffery; Carole Rattray; Karen L Kotloff; J Goldberg; Angela Manns; Charles S Rabkin; R Daniel; Barrie Hanchard; C Brown; M Hutchinson; D Zanizer; Joel Palefsky; Robert D Burk; Beverley Cranston; Barbara Clayman; Keerti V Shah
Adeno-associated virus and development of cervical neoplasia.
Journal of medical virology 1999;59(1):60-5.
1998: Howard D Strickler; M H Schiffman; Keerti V Shah; charles rabkin; J T Schiller; S Wacholder; Barbara Clayman; Raphael P Viscidi
A survey of human papillomavirus 16 antibodies in patients with epithelial cancers.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1998;7(4):305-13.
1998: C E Contreras; I N Ploton; Robert Siliciano; C L Karp; Raphael P Viscidi; Nirbhay Kumar
Mapping of specific and promiscuous HLA-DR-restricted T-cell epitopes on the Plasmodium falciparum 27-kilodalton sexual stage-specific antigen.
Infection and immunity 1998;66(8):3579-90.
1998: Howard D Strickler; Robert D Burk; Keerti V Shah; Raphael P Viscidi; A Jackson; G Pizza; F Bertoni; J T Schiller; Angela Manns; R Metcalf; W Qu; James J Goedert
A multifaceted study of human papillomavirus and prostate carcinoma.
Cancer 1998;82(6):1118-25.
1998: N Strunnikova; Stuart C Ray; C Lancioni; M Nguyen; Raphael P Viscidi
Evolution of human immunodeficiency virus type 1 in relation to disease progression in children.
Journal of human virology 1998;1(3):224-39.
1997: Howard D Strickler; Allan Hildesheim; Raphael P Viscidi; Keerti V Shah; B Goebel; James Drummond; D Waters; Yi Sun; NL Hubbert; Sholom Wacholder; L A Brinton; C L Han; P C Nasca; R McClimens; K Turk; V Devairakkam; S Leitman; C Martin; John T Schiller
Interlaboratory agreement among results of human papillomavirus type 16 enzyme-linked immunosorbent assays.
Journal of clinical microbiology 1997;35(7):1751-6.
1997: John S Lambert; Raphael P Viscidi; M C Walker; Barbara Clayman; M Winget; Mark Wolff; David H Schwartz
Antibody to human immunodeficiency virus type 1 (HIV-1) gp160 in mucosal specimens of asymptomatic HIV-1-infected volunteers parenterally immunized with an experimental recombinant HIV-1 IIIB gp160 vaccine. The National Institute of Allergy and Infectious Diseases-sponsored AIDS Vaccine Evaluation Group.
Clinical and diagnostic laboratory immunology 1997;4(3):302-8.
1997: Keerti V Shah; Raphael P Viscidi; Anthony J Alberg; Kathy J Helzlsouer; George W Comstock
Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1997;6(4):233-7.
1997: Raphael P Viscidi; Karen L Kotloff; Barbara Clayman; Karin G Russ; S Shapiro; Keerti V Shah
Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
Clinical and diagnostic laboratory immunology 1997;4(2):122-6.
1996: Thomas C Quinn; Charlotte A Gaydos; Mary Shepherd; LD Bobo; Edward W Hook; Raphael P Viscidi; Anne M Rompalo
Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships.
JAMA : the journal of the American Medical Association 1996;276(21):1737-42.
1996: S Iyengar; Keerti V Shah; Karen L Kotloff; S J Ghim; Raphael P Viscidi
Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein.
Clinical and diagnostic laboratory immunology 1996;3(6):733-9.
1996: Y Sun; Allan Hildesheim; Louise A Brinton; P C Nasca; Cornelia L Trimble; Robert J Kurman; Raphael P Viscidi; Keerti V Shah
Human papillomavirus-specific serologic response in vulvar neoplasia.
Gynecologic oncology 1996;63(2):200-3.
1996: David H Schwartz; Raphael P Viscidi; Oliver Laeyendecker; Haifeng Song; Stuart C Ray; N Michael
Predominance of defective proviral sequences in an HIV + long-term non-progressor.
Immunology letters 1996;51(1-2):3-6.
1996: Gary K Koski; I N Ploton; Raphael P Viscidi; Nirbhay Kumar
Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Peptide research 1996;9(3):127-35.
1995: Tzyy-choou Wu; F G Guarnieri; K Staveley-O'Carroll; Raphael P Viscidi; Hyam I Levitsky; L Hedrick; Kathleen R Cho; Thomas J August; Drew M Pardoll
Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(25):11671-5.
1995: N Strunnikova; Stuart C Ray; R A Livingston; E Rubalcaba; Raphael P Viscidi
Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression.
Journal of virology 1995;69(12):7548-58.
1995: I N Ploton; Benjamin Wizel; Raphael P Viscidi; Nirbhay Kumar
Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies.
Vaccine 1995;13(13):1161-9.
1995: B Nonnenmacher; N L Hubbert; Reinhard Kirnbauer; Keerti V Shah; N Muñoz; F X Bosch; S de Sanjosé; Raphael P Viscidi; Douglas Lowy; John T Schiller
Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.
The Journal of infectious diseases 1995;172(1):19-24.
1995: M Müller; Raphael P Viscidi; V Ulken; J N Bavinck; PETER HILL; Susan G Fisher; R Reid; N Munoz; A Schneider; Keerti V Shah
Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population.
The Journal of investigative dermatology 1995;104(1):138-41.
1994: Y Sun; Keerti V Shah; M Müller; N Muñoz; X F Bosch; Raphael P Viscidi
Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
Journal of clinical microbiology 1994;32(9):2216-20.
1994: Y Sun; J Eluf-Neto; F X Bosch; N Muñoz; M Booth; J M Walboomers; Keerti V Shah; Raphael P Viscidi
Human papillomavirus-related serological markers of invasive cervical carcinoma in Brazil.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(4):341-7.
1993: Raphael P Viscidi; Y Sun; B Tsuzaki; F X Bosch; N Muñoz; Keerti V Shah
Serologic response in human papillomavirus-associated invasive cervical cancer.
International journal of cancer. Journal international du cancer 1993;55(5):780-4.
1993: Sheila K West; Beatriz Munoz; LD Bobo; Thomas C Quinn; Harran Mkocha; Matthew Lynch; B B Mmbaga; Raphael P Viscidi
Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area.
Investigative ophthalmology & visual science 1993;34(11):3194-8.
1993: B Yang; Raphael P Viscidi; Robert H Yolken
Quantitative measurement of nonisotopically labeled polymerase chain reaction product.
Analytical biochemistry 1993;213(2):422-5.
1993: Raphael P Viscidi; LD Bobo; Edward W Hook; Thomas C Quinn
Transmission of Chlamydia trachomatis among sex partners assessed by polymerase chain reaction.
The Journal of infectious diseases 1993;168(2):488-92.
1993: A Funkhouser; M L Clements; S Slome; Barbara Clayman; Raphael P Viscidi
Antibodies to recombinant gp160 in mucosal secretions and sera of persons infected with HIV-1 and seronegative vaccine recipients.
AIDS research and human retroviruses 1993;9(7):627-32.
1993: B Yang; Robert H Yolken; Raphael P Viscidi
Quantitative polymerase chain reaction by monitoring enzymatic activity of DNA polymerase.
Analytical biochemistry 1993;208(1):110-6.
1992: Charlotte A Gaydos; LD Bobo; L Welsh; Edward W Hook; Raphael P Viscidi; Thomas C Quinn
Gene typing of Chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion.
Sexually transmitted diseases 1992;19(6):303-8.
1992: S M Holland; Alan P Hudson; LD Bobo; Judith A Whittum-Hudson; Raphael P Viscidi; Thomas C Quinn; Hugh R Taylor
Demonstration of chlamydial RNA and DNA during a culture-negative state.
Infection and immunity 1992;60(5):2040-7.
1992: François Coutlée; LD Bobo; H Abbass; G Dalabetta; N E Hook; Keerti V Shah; Raphael P Viscidi
Detection of HPV-16 in cell lines and cervical lavage specimens by a polymerase chain reaction-enzyme immunoassay assay.
Journal of medical virology 1992;37(1):22-9.
1992: M Müller; Raphael P Viscidi; Y Sun; E Guerrero; PETER HILL; F Shah; Franz X Bosch; N Muñoz; Lutz Gissmann; Keerti V Shah
Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
Virology 1992;187(2):508-14.
1992: Renu B Lal; Donna L Rudolph; Jonathan E Kaplan; Brian Hjelle; Paul H Levine; J E Coligan; Raphael P Viscidi
Identification of immunodominant epitopes in envelope glycoprotein of human T lymphotropic virus type II.
Virology 1992;186(1):274-9.
1992: David S newburg; Raphael P Viscidi; A Ruff; Robert H Yolken
A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor.
Pediatric research 1992;31(1):22-8.
1991: LD Bobo; F Coutlee; Robert H Yolken; Thomas C Quinn; Raphael P Viscidi
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay.
Journal of clinical microbiology 1991;29(12):2912.
1991: François Coutlée; P Saint-Antoine; C Olivier; Hélène Voyer; A Kessous-Elbaz; F Berrada; P Bégin; LM Giroux; Raphael P Viscidi
Evaluation of infection with human immunodeficiency virus type 1 by using nonisotopic solution hybridization for detection of polymerase chain reaction-amplified proviral DNA.
Journal of clinical microbiology 1991;29(11):2461-7.
1991: LD Bobo; Beatriz Munoz; Raphael P Viscidi; Thomas C Quinn; Harran Mkocha; Sheila K West
Diagnosis of Chlamydia trachomatis eye infection in Tanzania by polymerase chain reaction/enzyme immunoassay.
Lancet 1991;338(8771):847-50.
1991: François Coutlée; P Saint-Antoine; C Olivier; A Vessous-Elbaz; Hélène Voyer; F Berrada; P Bégin; LM Giroux; Raphael P Viscidi
Discordance between primer pairs in the polymerase chain reaction for detection of human immunodeficiency virus type 1: a role for taq polymerase inhibitors.
The Journal of infectious diseases 1991;164(4):817-8.
1991: F Coutleè; LD Bobo; K Mayur; Robert H Yolken; Raphael P Viscidi
Immunodetection of DNA with biotinylated RNA probes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids.
Analytical biochemistry 1991;198(1):217.
1991: François Coutlée; B Yang; LD Bobo; K Mayur; Robert H Yolken; Raphael P Viscidi
Enzyme immunoassay for detection of hybrids between PCR-amplified HIV-1 DNA and a RNA probe: PCR-EIA.
AIDS research and human retroviruses 1991;7(9):787.
1991: François Coutlée; Raphael P Viscidi; P Saint-Antoine; A Kessous; Robert H Yolken
The polymerase chain reaction: a new tool for the understanding and diagnosis of HIV-1 infection at the molecular level.
Molecular and cellular probes 1991;5(4):241-59.
1991: C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; Jan ter Meulen; Raphael P Viscidi
Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
Journal of clinical microbiology 1991;29(8):1579-88.
1991: Robert H Yolken; S Li; Jay Perman; Raphael P Viscidi
Persistent diarrhea and fecal shedding of retroviral nucleic acids in children infected with human immunodeficiency virus.
The Journal of infectious diseases 1991;164(1):61-6.
1991: François Coutlée; Keerti V Shah; Janet S Rader; JL Currie; Raphael P Viscidi
Detection of transcripts of human papillomaviruses 16 and 18 in cancer-derived cell lines and cervical biopsies by enzyme immunoassay for DNA-RNA hybrids following solution hybridization.
Journal of clinical microbiology 1991;29(5):968-74.
1991: Robert H Yolken; A M Sierra-Honigmann; Raphael P Viscidi
Solid phase capture method for the specific amplification of microbial nucleic acids--avoidance of false-positive and false-negative reactions.
Molecular and cellular probes 1991;5(2):151-6.
1991: J S Kinney; J H Conway; M W Hilgartner; Barbara Clayman; K Mayur; Robert H Yolken; Raphael P Viscidi
Humoral immune responses to gag and env proteins from human immunodeficiency virus type 1 in hemophiliac patients.
American journal of hematology 1991;36(1):35-41.
1991: Raphael P Viscidi; PETER HILL; S J Li; Erich Cerny; David Vlahov; Homayoon Farzadegan; Neal A Halsey; Gabor D Kelen; Thomas C Quinn
Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides.
Journal of acquired immune deficiency syndromes 1991;4(12):1190-8.
1990: Raphael P Viscidi; E Ellerbeck; L Garrison; K Midthun; M L Clements; Barbara Clayman; B Fernie; G Smith
Characterization of serum antibody responses to recombinant HIV-1 gp160 vaccine by enzyme immunoassay. NIAID AIDS Vaccine Clinical Trials Network.
AIDS research and human retroviruses 1990;6(11):1251-6.
1990: LD Bobo; F Coutlee; Robert H Yolken; Thomas C Quinn; Raphael P Viscidi
Diagnosis of Chlamydia trachomatis cervical infection by detection of amplified DNA with an enzyme immunoassay.
Journal of clinical microbiology 1990;28(9):1968-73.
1990: F Coutlee; E A Rubalcaba; Raphael P Viscidi; J E Gern; P A Murphy; Howard M Lederman
Quantitative detection of messenger RNA by solution hybridization and enzyme immunoassay.
The Journal of biological chemistry 1990;265(20):11601-4.
1990: François Coutlée; B Z Yang; LD Bobo; K Mayur; Robert H Yolken; Raphael P Viscidi
Enzyme immunoassay for detection of hybrids between PCR-amplified HIV-1 DNA and a RNA probe: PCR-EIA.
AIDS research and human retroviruses 1990;6(6):775-84.
1990: Raphael P Viscidi
Modification of cytosine residues on DNA.
Methods in enzymology 1990;184():600-7.
1989: Raphael P Viscidi; K Mayur; Howard M Lederman; Alan D Frankel
Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1.
Science (New York, N.Y.) 1989;246(4937):1606-8.
1989: Cheryl L Newman; John F Modlin; Robert H Yolken; Raphael P Viscidi
Solution hybridization and enzyme immunoassay for biotinylated DNA-RNA hybrids to detect enteroviral RNA in cell culture.
Molecular and cellular probes 1989;3(4):375-82.
1989: François Coutlée; LD Bobo; K Mayur; Robert H Yolken; Raphael P Viscidi
Immunodetection of DNA with biotinylated RNA probes: a study of reactivity of a monoclonal antibody to DNA-RNA hybrids.
Analytical biochemistry 1989;181(1):96-105.
1989: F Coutlee; Robert H Yolken; Raphael P Viscidi
Nonisotopic detection of RNA in an enzyme immunoassay using a monoclonal antibody against DNA-RNA hybrids.
Analytical biochemistry 1989;181(1):153-62.
1989: F Coutlee; Raphael P Viscidi; Robert H Yolken
Comparison of colorimetric, fluorescent, and enzymatic amplification substrate systems in an enzyme immunoassay for detection of DNA-RNA hybrids.
Journal of clinical microbiology 1989;27(5):1002-7.
1989: Robert H Yolken; F Coutlee; Raphael P Viscidi
New prospects for the diagnosis of viral infections.
The Yale journal of biology and medicine 1989;62(2):131-9.
1989: Raphael P Viscidi; C O'Meara; Homayoon Farzadegan; Robert H Yolken
Monoclonal antibody solution hybridization assay for detection of human immunodeficiency virus nucleic acids.
Journal of clinical microbiology 1989;27(1):120-5.
1989: J S Kinney; Raphael P Viscidi; S L Vonderfecht; J J Eiden; Robert H Yolken
Monoclonal antibody assay for detection of double-stranded RNA and application for detection of group A and non-group A rotaviruses.
Journal of clinical microbiology 1989;27(1):6-12.
1988: Raphael P Viscidi; Homayoon Farzadegan; F Leister; M L Francisco; Robert H Yolken
Enzyme immunoassay for detection of human immunodeficiency virus antigens in cell cultures.
Journal of clinical microbiology 1988;26(3):453-8.
1987: Raphael P Viscidi; Robert H Yolken
Molecular diagnosis of infectious diseases by nucleic acid hybridization.
Molecular and cellular probes 1987;1(1):3-14.
1986: P G Miotti; Raphael P Viscidi; J Eiden; E Cerny; Robert H Yolken
Centrifugation-augmented solid-phase immunoassay (CASPIA) for the rapid diagnosis of infectious diseases.
The Journal of infectious diseases 1986;154(2):301-8.
1986: Raphael P Viscidi; C J Connelly; Robert H Yolken
Novel chemical method for the preparation of nucleic acids for nonisotopic hybridization.
Journal of clinical microbiology 1986;23(2):311-7.
1986: Robert H Yolken; P Miotti; Raphael P Viscidi
Immunoassays for the diagnosis and study of viral gastroenteritis.
Pediatric infectious disease 1986;5(1 Suppl):S46-52.
1985: M Hanvanich; Raphael P Viscidi; Barbara Laughon; John G Bartlett; Robert H Yolken
Stool desorbing activity: a possible cause of false-positive reactions in competitive enzyme immunoassays.
Journal of clinical microbiology 1985;21(2):184-8.
1984: Barbara Laughon; Raphael P Viscidi; S L Gdovin; Robert H Yolken; John G Bartlett
Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens.
The Journal of infectious diseases 1984;149(5):781-8.
1984: Raphael P Viscidi; Barbara Laughon; M Hanvanich; John G Bartlett; Robert H Yolken
Improved enzyme immunoassays for the detection of antigens in fecal specimens. Investigation and correction of interfering factors.
Journal of immunological methods 1984;67(1):129-43.
1983: Raphael P Viscidi; Robert H Yolken; Barbara Laughon; John G Bartlett
Enzyme immunoassay for detection of antibody to toxins A and B of Clostridium difficile.
Journal of clinical microbiology 1983;18(2):242-7.
1983: Raphael P Viscidi; Barbara Laughon; Robert H Yolken; P Bo-Linn; T Moench; Robert W Ryder; John G Bartlett
Serum antibody response to toxins A and B of Clostridium difficile.
The Journal of infectious diseases 1983;148(1):93-100.
1982: Raphael P Viscidi; A Geller; W Caplan; G A Natsios; R A Gleckman
Prosthetic valve endocarditis caused by Mycobacterium chelonei: case report and literature review.
Heart & lung : the journal of critical care 1982;11(6):555-9.
1981: Raphael P Viscidi; S Willey; John G Bartlett
Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
Gastroenterology 1981;81(1):5-9.
1981: Raphael P Viscidi; John G Bartlett
Antibiotic-associated pseudomembranous colitis in children.
Pediatrics 1981;67(3):381-6.